← SynDRA
ROPINIROLE
SynDRA canonical compound SYN0001023 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | DRD3 |
| Mechanism of action | Dopamine receptor agonist |
| Indication | Parkinson's Disease | restless leg syndrome |
| Disease area | neurology/psychiatry |
All known targets
- DRD2
- DRD3
- DRD4
- ADRA2A
- HTR2A
- ADRA2C
- DRD1
- DRD5
- ADRA2B
- HTR1A
- HTR2B
- HTR1D
Mechanisms of action (all sources)
- Dopamine receptor agonist
- DRD2 AGONIST
- D2-like dopamine receptor agonist
- DRD3 AGONIST
- DRD4 AGONIST
- DRD3 MODULATOR
- DRD2 MODULATOR
Drug classes
- Dopamine Agonists
- Anti-Dyskinesia Agents
- Antiparkinson Agents
- Central Nervous System Agents
- Dopamine Agents
- Neurotransmitter Agents
- Nonergot Dopamine Agonist
ATC classes
- N04B · DOPAMINERGIC AGENTS
Cross-references
Synonyms
- ropinirol
- requip
- ropinirole hydrochloride
- ropinirole HCl
- Ropinirol
- NSC-758917
- SK&F-101468
- Ropitor
- Ropinirolum
- ReQuip CR
- ReQuip XL
- SKF 101468
- Adartrel (TN)
- Requip (TN)
- Ropark (TN)
- Ropinirol[INN-Spanish]
- Ropinirole (INN)
- Ropinirole [INN:BAN]
- Ropinirolum [INN-Latin]
- Ropitor (TN)
- SK&F 101468
- SK&F-101,468
- 4-[2-(Dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one
- 4-[2-(Dipropylamino)ethyl]indoline-2-one
- 4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one
- Narapin
- NSC 758917
- SKF-101468
- 4-[2-(dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one
- CHEBI:8888
- DTXCID6025195
- Adartrel
- 4-[2-(dipropylamino)ethyl]-2,3-dihydro-1h-indol-2-one
- 2H-Indol-2-one, 4-(2-(dipropylamino)ethyl)-1,3-dihydro-
- sk&f-101468a
- 4-(2-(Dipropylamino)ethyl)-1,3-dihydro-2H-indol-2-one
- 4-(2-(dipropylamino)ethyl)-3H-indol-2-ol
- 4-[2-(dipropylamino)ethyl]-3H-indol-2-ol
Reported adverse events
- Hallucination
- Hypersensitivity
- Nervousness
- Syncope
- Vomiting
- Amnesia
- Anxiety
- Arthralgia
- Arthritis
- Bronchitis
- Constipation
- Cough
Look up ROPINIROLE in the interactive SynDRA portal →